PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis
Sven Francque, An Verrijken, Sandrine Caron et al. · Journal of Hepatology · 2015
Cited by 357 works. doi:10.1016/j.jhep.2015.02.019
Authors
- Sven Francque
- An Verrijken
- Sandrine Caron
- Janne Prawitt
- Réjane Paumelle
- Bruno Derudas
- Philippe Lefèbvre
- Marja‐Riitta Taskinen
- Wim Van Hul
- Ilse L. Mertens
- Guy Hubens
- Eric Van Marck
- Peter P. Michielsen
- Luc Van Gaal
- Bart Staels
References
- Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
- The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
- Systematic review: the epidemiology and natural history of non‐alcoholic fatty liver disease and non‐alcoholic steatohepatitis in adults
- Ursodeoxycholic Acid or Clofibrate in the Treatment of Non–Alcohol–Induced Steatohepatitis: A Pilot Study
- Endocrine Regulation of the Fasting Response by PPARα-Mediated Induction of Fibroblast Growth Factor 21
- A position statement on NAFLD/NASH based on the EASL 2009 special conference
- Endpoints and clinical trial design for nonalcoholic steatohepatitis
- Randomized Controlled Trial Testing the Effects of Weight Loss on Nonalcoholic Steatohepatitis
- Alternative M2 Activation of Kupffer Cells by PPARδ Ameliorates Obesity-Induced Insulin Resistance
- Sorting out the roles of PPAR in energy metabolism and vascular homeostasis